Back

Plasma proteomics identify fibroblast growth factor 5 as a biomarker for genetically proven Familial Hypercholesterolemia

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment: biomarkers Biomarkers ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Associate Professor Andrea Baragetti

University of Milan, Milan (Italy)

3 More presentations in this session

Presentation thumbnail
The association of lipoprotein(a) with patient characteristics and mortality in a primary prevention cohort: data from our clinic database
Doctor L. Cho (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Plasma levels of amyloid beta 1-40 are associated with ultrasonographic morphological characteristics related with carotid plaque vulnerability in individuals without cardiovascular disease
Doctor D. Delialis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Association of random glucose to albumin ratio with post-contrast acute kidney injury and clinical outcomes in patients with ST-elevation myocardial infarction
Mr Y. Liu (Guangzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment: biomarkers

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources